Rising Prevalence of Venous Thromboembolism and Increasing Usage of NOACS as Alternatives to Warfarin are Expected to drive the Global Anticoagulation Therapy Market in the forecast period of 2019 -2026

Global Anticoagulation Therapy Market is projected to register a substantial CAGR of 8.3% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Access Full Report at https://databridgemarketresearch.com/reports/global-anticoagulation-therapy-market

Drivers: Global Anticoagulation Therapy Market

  • Rising prevalence of venous thromboembolism and pulmonary embolism
  • Increasing usage of NOACS as alternatives to warfarin

Restraint:

  • Increasing government restriction

Opportunity:

  • Strategic initiatives by the market players

Challenge:

  • Side-Effects Of Heparin

Market Trends:

Global anticoagulation therapy market is segmented into nine notable segments which are treatment, therapeutic class, drug type, route of administration, therapeutic area, procedure, type, end user and distribution channel.

  • On the basis of treatment, the market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), arterial thromboembolism (AT), stroke and others. The deep vein thrombosis (DVT) segment is expected to lead global anticoagulation therapy market in forecast period of 2019-2026. 
  • On the basis of therapeutic class, the market is segmented into novel oral anticoagulation (NOAC), heparin, vitamin k antagonists and others
  • On the basis of drug type, the market is segmented into bivalirudin, dabigatran, edoxaban, betrixaban, rivaroxaban, apixaban, enoxaparin, delteparin and others
  • On the basis of route of administration, the market is segmented into oral and injectable
  • On the basis of therapeutic area, the market is segmented into cardiovascular diseases, oncology, respiratory, nephrology, CNS and others
  • On the basis of procedure, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis and heart valve replacement
  • On the basis of type, the market is segmented into generics and branded
  • On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others
  • On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy

Major Players: Global Anticoagulation Therapy Market

The key market players for global anticoagulation therapy market are listed below:

  • Hikma Pharmaceuticals PLC
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Eisai Co., Ltd.
  • Pfizer Inc.
  • Sanofi
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Aspen Holdings
  • Shanghai Fosun Pharmaceutical(Group)Co., Ltd.
  • Cipla Inc
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • DAIICHI SANKYO COMPANY, LIMITED
  • Eagle Pharmaceuticals, Inc.
  • Endo Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corporation
  • Portola Pharmaceuticals, Inc.
  • Taro Pharmaceutical Industries Ltd.